Business Context and Reporting Period
This Form 8-K is filed by LMF Acquisition Opportunities, Inc. (LMAO), a Special Purpose Acquisition Company (SPAC), on September 28, 2022. The filing announces the effectiveness of a definitive proxy statement/prospectus regarding a proposed business combination with SeaStar Medical, Inc. (referred to as SeaStar Medical). The transaction is governed by a Merger Agreement dated April 21, 2022.
Key Financial Metrics
This filing is a current report regarding a corporate event and does not contain audited financial statements, revenue, profit, cash flow, margin, debt, or liquidity metrics for either LMAO or SeaStar Medical. Investors are directed to the Form S-4 Registration Statement for detailed financial data.
Material Changes and Transaction Details
- Transaction Status: LMAO has filed a definitive proxy statement/prospectus with the SEC.
- Special Meeting: A special meeting of stockholders is scheduled for October 18, 2022, at 10:00 a.m. Eastern Time at LMAO's offices in Tampa, Florida.
- Voting Record Date: Stockholders of record as of September 23, 2022 are eligible to vote on the Business Combination.
- Securities: LMAO's Class A Common Stock (LMAO), Units (LMAOU), and Warrants (LMAOW) trade on The Nasdaq Stock Market LLC.
Outlook, Risks, and Management Commentary
Management emphasizes that the transaction is subject to significant risks and uncertainties. Key forward-looking statements and risks include:
- Completion Risk: The business combination may not be completed in a timely manner or at all, potentially affecting security prices.
- Conditions Precedent: Closing is contingent upon stockholder approval and the satisfaction of a minimum trust account amount following redemptions.
- Operational Risks: Risks include the ability to commercialize SeaStar Medical's products, regulatory approvals, competition, and the potential need for additional capital.
- Listing Risk: Uncertainty regarding the ability to maintain the listing of securities on Nasdaq post-combination.
- Profitability: SeaStar Medical may never achieve or sustain profitability.
Investor Verification Checklist
- Verify the Form S-4 Registration Statement (File No. 333-264993) for detailed financial projections and risk factors.
- Confirm the minimum trust account amount required to close the transaction and current redemption levels.
- Review the Merger Agreement terms regarding the implied valuation of SeaStar Medical and the exchange ratio for shareholders.
- Check for any unsolicited offers or alternative transactions that could interfere with the proposed combination.
- Monitor the October 18, 2022 special meeting outcome for stockholder approval.